COLUSSI, Gian Luca
 Distribuzione geografica
Continente #
NA - Nord America 3.502
AS - Asia 2.870
EU - Europa 1.457
SA - Sud America 723
AF - Africa 98
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.662
Nazione #
US - Stati Uniti d'America 3.371
SG - Singapore 1.142
IT - Italia 630
BR - Brasile 510
CN - Cina 497
VN - Vietnam 404
HK - Hong Kong 277
DE - Germania 159
FR - Francia 95
FI - Finlandia 92
JP - Giappone 84
IN - India 80
GB - Regno Unito 76
AR - Argentina 73
RU - Federazione Russa 71
ID - Indonesia 67
PL - Polonia 60
TR - Turchia 58
CA - Canada 53
MX - Messico 51
NL - Olanda 49
BD - Bangladesh 48
UA - Ucraina 45
SE - Svezia 40
AT - Austria 33
ES - Italia 32
ZA - Sudafrica 27
EC - Ecuador 25
IQ - Iraq 24
PE - Perù 24
CO - Colombia 23
SA - Arabia Saudita 23
PK - Pakistan 21
VE - Venezuela 20
CL - Cile 19
MY - Malesia 19
MA - Marocco 15
PH - Filippine 14
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
IR - Iran 12
UZ - Uzbekistan 12
CH - Svizzera 11
EG - Egitto 11
KE - Kenya 11
IE - Irlanda 10
BO - Bolivia 9
KR - Corea 9
TN - Tunisia 9
BE - Belgio 8
RS - Serbia 8
TW - Taiwan 8
JO - Giordania 7
LT - Lituania 7
UY - Uruguay 7
AZ - Azerbaigian 6
SN - Senegal 6
AU - Australia 5
BH - Bahrain 5
IL - Israele 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
CR - Costa Rica 4
DZ - Algeria 4
GT - Guatemala 4
HN - Honduras 4
OM - Oman 4
PT - Portogallo 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
ET - Etiopia 3
GE - Georgia 3
HU - Ungheria 3
JM - Giamaica 3
KW - Kuwait 3
KZ - Kazakistan 3
NP - Nepal 3
RO - Romania 3
CY - Cipro 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EU - Europa 2
GH - Ghana 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
MM - Myanmar 2
NO - Norvegia 2
PS - Palestinian Territory 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BT - Bhutan 1
CV - Capo Verde 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
Totale 8.641
Città #
Singapore 653
Ashburn 482
San Jose 363
Fairfield 314
Hong Kong 260
Santa Clara 243
Beijing 177
Houston 158
Ho Chi Minh City 135
Woodbridge 133
Dallas 132
Cambridge 118
Seattle 112
Wilmington 88
Hanoi 87
Tokyo 78
Helsinki 74
Council Bluffs 72
Los Angeles 70
New York 47
Ann Arbor 46
Ferrara 46
Lauterbourg 44
Milan 43
São Paulo 41
Princeton 40
Gdansk 38
Redwood City 38
Chandler 37
Jakarta 36
Nuremberg 34
Chicago 32
Orem 29
Munich 27
Hefei 26
Izmir 26
Frankfurt am Main 23
Jacksonville 23
Mexico City 23
Da Nang 21
Brooklyn 20
Chennai 20
Lima 20
Buffalo 19
Haiphong 19
Johannesburg 19
San Diego 19
Addison 18
London 18
Rome 18
Nanjing 17
Warsaw 17
Belo Horizonte 16
Moscow 16
Rio de Janeiro 16
Stockholm 16
Atlanta 15
Ribeirão Prêto 15
Phoenix 14
Boston 13
Dearborn 13
Vienna 13
Washington 13
Casalgrande 12
Denver 12
Lappeenranta 11
Manchester 11
Mountain View 11
Tampa 11
Trieste 11
Baghdad 10
Bologna 10
Jeddah 10
Kuala Lumpur 10
New Delhi 10
Quito 10
Salt Lake City 10
Salvador 10
Santiago 10
Bari 9
Hải Dương 9
Montreal 9
Nairobi 9
San Francisco 9
Shanghai 9
Tianjin 9
Assago 8
Boardman 8
Campinas 8
Falkenstein 8
Fortaleza 8
Newtown Square 8
Porto Alegre 8
Tashkent 8
Toronto 8
Amman 7
Amsterdam 7
Brasília 7
Dublin 7
Falls Church 7
Totale 5.192
Nome #
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 226
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 216
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 213
Pain and Frailty in Hospitalized Older Adults 213
Antibiotic use and associated factors in a large sample of hospitalised older people 208
Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register 206
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 195
Comparison between drug therapy-based comorbidity indices and the Charlson Comorbidity Index for the detection of severe multimorbidity in older subjects 193
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 185
Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people 184
Implementation of the frailty index in hospitalized older patients: results from the REPOSI register 172
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 167
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 166
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 164
Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients 163
Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study 161
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 161
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 159
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 146
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 146
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 143
Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry 141
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 139
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 137
Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry 134
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 134
Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients 133
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 132
What changed in the Italian internal medicine and geriatric wards during the lockdown 127
Initiation of Psycholeptic Medication During Hospitalization With Recommendation for Discontinuation After Discharge 121
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 119
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 119
Plasma lipoprotein(A) levels as determinants of arterial stiffening in hypertension 117
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 113
Relation between drug therapy-based comorbidity indices, Charlson's comorbidity index, polypharmacy and mortality in three samples of older adults 111
COVID-19 Accelerated Cognitive Decline in Elderly Patients with Pre-Existing Dementia Followed up in an Outpatient Memory Care Facility 107
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 107
Diagnostic role of CD64 expression on neutrophils as biomarker for blood stream infection in liver cirrhosis: some preliminary findings 93
Polyphenols rich diets and risk of type 2 diabetes 92
Effects of antithrombotic agents on ophthalmological outcomes, cardiovascular risk, and mortality in hypertensive patients with retinal vein occlusion: An exploratory retrospective study 90
Elevated Intrarenal Resistive Index Predicted Faster Renal Function Decline and Long-Term Mortality in Non-Proteinuric Chronic Kidney Disease 89
Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients 88
Effect of Combined Proteinuria and Increased Renal Resistive Index on Chronic Kidney Disease Progression: A Retrospective Longitudinal Study 85
Development and Validation of the Acute PNeumonia Early Assessment Score for Safely Discharging Low-Risk SARS-CoV-2-Infected Patients from the Emergency Department 83
Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients 82
Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: A pilot study 77
Aortic stiffness and indexes of disease severity in subjects with previous COVID-19 penumonia:a follow-up study 76
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis 76
‘Help yourself, so the (circadian) rhythms help you’: Chronobiological insights to promote physical and mental health 73
Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with covid-19 pneumonia: A prospective study 68
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 68
Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis 68
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 68
Secondary hyperparathyroidism is associated with postpartum blood pressure in preeclamptic women and normal pregnancies 66
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 65
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 65
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge 65
Interactions between vitamin D levels, cardiovascular risk factors, and atherothrombosis markers in patients with symptomatic peripheral artery disease 64
Aldosterone and Left Ventricular Remodeling 63
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 63
Role of MR-proADM and Monocyte CD169 in Predicting In-Hospital and 60-Day Mortality in COVID-19 Patients 62
Relationships between NAFLD biochemical scores and left ventricular geometric pattern in naive essential hypertensive patients 60
Benzodiazepines: an old class of new antihypertensive drugs? 59
Echocardiographic Comparison of COVID-19 Patients with or without Prior Biochemical Evidence of Cardiac Injury after Recovery 59
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 58
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 57
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 55
Effect of intermediate/high versus low dose heparin on the thromboembolic and hemorrhagic risk of unvaccinated COVID-19 patients in the emergency department 54
Prognostic scores and early management of septic patients in the emergency department of a secondary hospital: results of a retrospective study 50
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 49
Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study 45
Hypertension and type 2 diabetes: lights and shadows about causality 44
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 39
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 37
Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron 35
Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study 34
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 30
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 30
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 29
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 28
Functioning or Non-Functioning Adrenal Adenoma? Probably, Just a Matter of Time 28
HICCups and inappropriate ADH secretion syndrome as presentations of tick-borne disease 27
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kγ 27
Novel role for SGK3 in glucose homeostasis revealed in SGK3/Akt2 double-null mice 25
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 25
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 25
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 23
Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1: A systematic review and meta-analysis of randomised controlled trials 23
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 22
Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients 22
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 22
Has the time come to change the treatment criteria for patients with chronic kidney disease? The “hypofiltering nephron” hypothesis 22
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 22
Omega-3 polyunsaturated fatty acids decrease plasma lipoprotein(a) levels in hypertensive subjects 22
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 21
ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature 20
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 19
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 18
Microalbuminuria and plasma aldosterone levels in nondiabetic treatment-naive patients with hypertension 17
Are Marital Status and Quality Risk Factors for Cardiovascular Diseases? 16
Totale 8.865
Categoria #
all - tutte 40.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 0 0 0 0 48 86 31
2021/2022633 139 103 30 35 66 41 15 46 24 18 21 95
2022/2023185 39 17 6 17 17 14 28 11 19 4 8 5
2023/2024294 8 7 23 19 16 53 10 8 4 13 55 78
2024/20251.585 30 11 66 12 238 168 126 86 144 270 252 182
2025/20264.749 368 254 566 554 652 366 490 379 513 607 0 0
Totale 8.926